Diabetologia: The warning management system of patient electronic data is conducive to the lipid-lowering treatment of patients with type 2 diabetes

Background introduction: The Disease Management Programme (DMP) originated in the United States

Common chronic diseases maintenance and treatment provide advice or programs to regularly observe and supervise the implementation of patients, check whether these patients take medicines on time and correctly, whether they have really changed their original life>

Methods: This observational study evaluated the relationship between the use of DMP by general practitioners in a cohort of type 2 diabetes patients and the lipid-lowering drug kitchen.

Results: Compared with patients treated by control general practitioners, patients who did not receive a lipid-lowering drug prescription in the previous year of being included in the DMP were statistically more likely to receive a lipid-lowering drug prescription (OR 1.

Table 1 Baseline (2011) characteristics of patients treated by general practitioners in the exposure group and the control group

Table 1 Baseline (2011) characteristics of patients treated by general practitioners in the exposure group and the control group

Table 2 Logistic regression analysis of the influence of DMP using lipid-lowering drug prescriptions in 2012

Table 2 Logistic regression analysis of the influence of DMP using lipid-lowering drug prescriptions in 2012

Conclusion: The use of DMP to check the medication status of the population and prompt patients to follow the prescription and treatment measures recommended by the guidelines can increase the amount of lipid-lowering drugs prescribed by general practitioners

Using DMP to check the medication status of the population, and remind patients to follow the prescription and treatment measures recommended by the guide, can increase the prescription of lipid-lowering drugs for general practitioners

Charles MH, Thomsen JL, Christensen B,et al.

Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.


Leave a message here